<DOC>
	<DOCNO>NCT01846481</DOCNO>
	<brief_summary>This randomize , 4-sequence , 2-period , double-blind , placebo control study male female subject American Psychiatric Association Diagnostic Statistical Manual DSM-IV-TR diagnosis cocaine abuse .</brief_summary>
	<brief_title>A Randomized , 4-sequence , 2-period , Double-blind , Placebo Controlled Study With DSM-IV-TR Diagnosis Cocaine Abuse</brief_title>
	<detailed_description>There 28-day screening period eligible subject remain resident clinic evening Day -1 morning Day 9 . On morning Day 1 , 50 mg intravenous ( IV ) infusion cocaine administer 10 minute subject . If none stop criterion meet intervene safety concern , subject randomize one treatment sequence Day 3 . On dose day , Day 3 Day 6 , subject fast least 8 hour dose cocaine either RBP-8000 200 mg , RBP-8000 100 mg match placebo .</detailed_description>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<criteria>Male female volunteer age 2150 year , inclusive Body mass index ( BMI ) 1832 kg/m^2 weight least 50 kg Not currently seek treatment substance abuse substance dependence Subject healthy , opinion Principal Investigator cocaine abuse ; determine absence clinically significant medical/psychiatric history finding , particularly cardiovascular central nervous system ( CNS ) disease , physical examination , normal renal function , ECG finding , vital sign , laboratory result screen Males agree refrain sperm donation entire duration study , least 90 day last dose study drug Has experience use cocaine smoke IV route least 6 time past 12 month positive urine drug screen cocaine prior study intake ( Day 2 ) . Has experience use cocaine smoke IV route past 3 month positive urine drug screen cocaine screen prior study checkin clinic Be able verbalize understanding consent form , able provide write informed consent , verbalize willingness complete study procedure , prior initiation protocolspecific procedures Meet DSMIVTR criterion current cocaine abuse Be able comply protocol requirement , rule , regulation study site , likely complete study procedure opinion Principal Investigator Current past history seizure disorder , include alcohol and/or stimulantrelated seizure , febrile seizure , significant family history idiopathic seizure disorder . Have previous clinically significant reaction cocaine , include loss consciousness seizure Current alcohol dependence current drug dependence accord DSMIVTR criterion ( exclude nicotine caffeine ) Clinically significant history cardiac disease , include cardiovascular conduction abnormality ECG evidence cardiac abnormality QTcF great equal 450 male subject 470 female subject measure 12lead ECG History liver disease current elevation aspartate aminotransferase ( AST ) alanine aminotransferase ( ALT ) exceed 3x upper limit normal Be probation parole , and/or current pending legal charge potential incarceration could interfere study schedule Women positive pregnancy test screening ; woman pregnant lactate seek become pregnant Women childbearing potential ( sexually active male ) fail use medically acceptable contraception method ( e.g. , oral injectable contraceptive , approve hormonal implant topical patch , intrauterine device , double barrier method , barrier plus spermicide ) . A woman childbearing potential define female less 2 year postmenopausal undergone hysterectomy surgical sterilization , e.g. , bilateral tubal ligation , bilateral ovariectomy ( oophorectomy ) . Females postmenopausal confirm follicle stimulate hormone ( FSH ) test initial screening Males agree use barrier contraception spermicide engage sexual activity female childbearing potential study medication , least 28 day last dose study medication History clinically significant severe allergic anaphylactic reaction</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Cocaine</keyword>
</DOC>